Status report
Get it in writing
The official USPTO status record for HYPHEN BIOMED, serial 86339071, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
HYPHEN BIOMEDSerial 86339071 · Principal Register
Live · Registered
Owner: Sysmex Corporation
Class 005 - Pharmaceuticals
Filed Jul 16, 2014
Registered May 03, 2016
The record shows that “HYPHEN BIOMED” is a live Principal Register trademark owned by Sysmex Corporation, a corporation organized in Japan, and it has been renewed as of May 30 2026. The registration covers Class 005 – pharmaceuticals and, more specifically, diagnostic reagents and preparations for medical, veterinary or clinical diagnostic purposes, including reagents for immunochemistry, coagulation, immunohematology, chemistry, microbiology, hematology, immunology, serology and related testing controls. Because the listed goods focus on diagnostic and laboratory reagents, a similar name used for those kinds of products would raise the closest record‑based concern, while uses in unrelated fields would be farther from the scope shown. The record does not give the owner control over every possible use of the words “Hyphen” or “Biomed.” The most recent meaningful event is the May 30 2026 acceptance of the Section 8 and 9 renewal filing. No oppositions, cancellations or other enforcement actions appear in the supplied history. I’d treat this as a meaningful concern if you plan a comparable name in the diagnostic‑reagent space.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.